Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziqing Zeng

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2024
Preclinical imaging evaluation of a bispecific antibody targeting hPD1/CTLA4 using humanized miceXingguo Hou, Song Liu, Ziqing Zeng, et al.
Cancer Biology & Medicine|August 30, 2021
The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinomaJian Wang, Fan Yang, Qian Sun, et al.
Translational Lung Cancer Research|January 25, 2021
Survival benefit and toxicity profile of adjuvant icotinib for patients with <i>EGFR</i> mutation-positive non-small cell lung carcinoma: a retrospective studyZiqing Zeng, Bo Yan, Yulong Chen, et al.
Molecular Pharmaceutics|January 25, 2024
Construction and Preclinical Evaluation of <sup>124</sup>I/<sup>125</sup>I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3Jinping Tao, Ziqing Zeng, Chengxue He, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2024
Preclinical imaging evaluation of a bispecific antibody targeting hPD1/CTLA4 using humanized miceXingguo Hou, Song Liu, Ziqing Zeng, et al.
Cancer Biology & Medicine|August 30, 2021
The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinomaJian Wang, Fan Yang, Qian Sun, et al.
Translational Lung Cancer Research|January 25, 2021
Survival benefit and toxicity profile of adjuvant icotinib for patients with <i>EGFR</i> mutation-positive non-small cell lung carcinoma: a retrospective studyZiqing Zeng, Bo Yan, Yulong Chen, et al.
Molecular Pharmaceutics|January 25, 2024
Construction and Preclinical Evaluation of <sup>124</sup>I/<sup>125</sup>I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3Jinping Tao, Ziqing Zeng, Chengxue He, et al.
Pageof 3